NCT00729495View on ClinicalTrials.gov

Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib

PHASE1CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2008

Conditions

Healthy Volunteer

Interventions

DRUG

celecoxib

dose form

Trial Locations (1)

Unknown

Research, Springfield

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

POZEN

INDUSTRY